OVID Ovid Therapeutics | $0.79
| 6/18/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $11.00 -> $5.00 | Low | View details for BTIG Research rating of Ovid Therapeutics (NASDAQ:OVID) on 6/18/2024 |
AVTE Aerovate Therapeutics | $1.41
-14.5% | 6/17/2024 | Downgraded by | BTIG Research | Analyst J. Harrison | Buy -> Neutral | | N/A | View details for BTIG Research rating of Aerovate Therapeutics (NASDAQ:AVTE) on 6/17/2024 |
STTK Shattuck Labs | $4.59
-7.8% | 6/17/2024 | Downgraded by | BTIG Research | Analyst K. Pohlman | Buy -> Neutral | | Low | View details for BTIG Research rating of Shattuck Labs (NASDAQ:STTK) on 6/17/2024 |
STAA STAAR Surgical | $41.23
+2.9% | 6/11/2024 | Upgraded by | BTIG Research | Analyst R. Zimmerman | Neutral -> Buy | $46.00 | Low | View details for BTIG Research rating of STAAR Surgical (NASDAQ:STAA) on 6/11/2024 |
SOFI SoFi Technologies | $6.42
-0.6% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of SoFi Technologies (NASDAQ:SOFI) on 6/7/2024 |
UPST Upstart | $22.22
-0.8% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Sell | $14.00 | Low | View details for BTIG Research rating of Upstart (NASDAQ:UPST) on 6/7/2024 |
|
SYF Synchrony Financial | $43.63
+1.3% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Buy | $60.00 | Low | View details for BTIG Research rating of Synchrony Financial (NYSE:SYF) on 6/7/2024 |
UPBD Upbound Group | $31.53
+0.1% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Buy | $45.00 | Low | View details for BTIG Research rating of Upbound Group (NASDAQ:UPBD) on 6/7/2024 |
RM Regional Management | $27.11
0.0% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of Regional Management (NYSE:RM) on 6/7/2024 |
PRG PROG | $35.57
+1.1% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of PROG (NYSE:PRG) on 6/7/2024 |
LPRO Open Lending | $5.84
+1.7% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of Open Lending (NASDAQ:LPRO) on 6/7/2024 |
OMF OneMain | $48.29
+0.6% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of OneMain (NYSE:OMF) on 6/7/2024 |
LC LendingClub | $8.26
-0.4% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Buy | $12.00 | Low | View details for BTIG Research rating of LendingClub (NYSE:LC) on 6/7/2024 |
FCFS FirstCash | $109.27
0.0% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of FirstCash (NASDAQ:FCFS) on 6/7/2024 |
DFS Discover Financial Services | $126.95
+1.0% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of Discover Financial Services (NYSE:DFS) on 6/7/2024 |
AAN Aaron's | $10.02
-0.4% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of Aaron’s (NYSE:AAN) on 6/7/2024 |
COF Capital One Financial | $137.41
+0.2% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of Capital One Financial (NYSE:COF) on 6/7/2024 |
BFH Bread Financial | $40.84
+0.5% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of Bread Financial (NYSE:BFH) on 6/7/2024 |
ATLC Atlanticus | $27.54
+0.0% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Buy | $45.00 | Low | View details for BTIG Research rating of Atlanticus (NASDAQ:ATLC) on 6/7/2024 |
CRMT America's Car-Mart | $57.81
-6.4% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of America’s Car-Mart (NASDAQ:CRMT) on 6/7/2024 |
AXP American Express | $229.32
+0.5% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of American Express (NYSE:AXP) on 6/7/2024 |
ALLY Ally Financial | $40.05
+0.8% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Buy | $51.00 | Low | View details for BTIG Research rating of Ally Financial (NYSE:ALLY) on 6/7/2024 |
AFRM Affirm | $30.53
-0.9% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of Affirm (NASDAQ:AFRM) on 6/7/2024 |
BE Bloom Energy | $13.64
-2.2% | 6/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $19.00 -> $21.00 | Low | View details for BTIG Research rating of Bloom Energy (NYSE:BE) on 6/6/2024 |
FIP FTAI Infrastructure | $8.37
+4.9% | 6/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $10.00 -> $11.00 | Low | View details for BTIG Research rating of FTAI Infrastructure (NASDAQ:FIP) on 6/6/2024 |
CORZ Core Scientific | $8.91
-8.0% | 6/6/2024 | Target Raised by | BTIG Research | Analyst G. Lewis | Buy -> Buy | $8.00 -> $10.00 | Low | View details for BTIG Research rating of Core Scientific (NASDAQ:CORZ) on 6/6/2024 |
SHOO Steven Madden | $43.86
+0.4% | 6/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $50.00 -> $53.00 | Low | View details for BTIG Research rating of Steven Madden (NASDAQ:SHOO) on 6/6/2024 |
BOOT Boot Barn | $133.81
+2.6% | 6/5/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $125.00 -> $150.00 | Low | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 6/5/2024 |
GWRE Guidewire Software | $135.53
-0.2% | 6/5/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $135.00 -> $140.00 | Low | View details for BTIG Research rating of Guidewire Software (NYSE:GWRE) on 6/5/2024 |
CRWD CrowdStrike | $389.51
-0.2% | 6/5/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $432.00 -> $402.00 | Low | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 6/5/2024 |
GTLB GitLab | $43.01
-1.0% | 6/4/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $71.00 -> $58.00 | Low | View details for BTIG Research rating of GitLab (NASDAQ:GTLB) on 6/4/2024 |
IMXI International Money Express | $20.51
-1.0% | 6/3/2024 | Initiated by | BTIG Research | Analyst A. Harte | Buy | $25.00 | Low | View details for BTIG Research rating of International Money Express (NASDAQ:IMXI) on 6/3/2024 |
SMRT SmartRent | $2.40
-0.4% | 6/3/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $4.30 -> $4.00 | Low | View details for BTIG Research rating of SmartRent (NYSE:SMRT) on 6/3/2024 |
BRZE Braze | $35.13
-0.8% | 5/31/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $68.00 -> $62.00 | Low | View details for BTIG Research rating of Braze (NASDAQ:BRZE) on 5/31/2024 |
S SentinelOne | $18.17
-1.4% | 5/31/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $30.00 -> $23.00 | Low | View details for BTIG Research rating of SentinelOne (NYSE:S) on 5/31/2024 |
ZS Zscaler | $179.41
-2.7% | 5/31/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $258.00 -> $220.00 | Low | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 5/31/2024 |
ACIU AC Immune | $4.07
-0.2% | 5/31/2024 | Initiated by | BTIG Research | Analyst T. Shrader | Buy | $8.00 | Low | View details for BTIG Research rating of AC Immune (NASDAQ:ACIU) on 5/31/2024 |
GLNG Golar LNG | $28.45
-0.7% | 5/29/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $30.00 -> $36.00 | Low | View details for BTIG Research rating of Golar LNG (NASDAQ:GLNG) on 5/29/2024 |
CORZ Core Scientific | $8.91
-8.0% | 5/29/2024 | Upgraded by | BTIG Research | Analyst G. Lewis | Neutral -> Buy | $8.00 | Low | View details for BTIG Research rating of Core Scientific (NASDAQ:CORZ) on 5/29/2024 |
GMED Globus Medical | $67.04
+0.5% | 5/29/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $63.00 -> $72.00 | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 5/29/2024 |
Must-See: Elon’s New Invention is Absolutely Insane (Ad) Could Elon's New Device be Bigger than the iPhone?
According to 30-year Silicon Valley and Wall Street veteran, Eric Fry…
This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… |
DECK Deckers Outdoor | $1,008.46
-0.9% | 5/24/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $1,020.00 -> $1,120.00 | Low | View details for BTIG Research rating of Deckers Outdoor (NYSE:DECK) on 5/24/2024 |
MGNX MacroGenics | $4.12
-4.0% | 5/24/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $24.00 -> $9.00 | Low | View details for BTIG Research rating of MacroGenics (NASDAQ:MGNX) on 5/24/2024 |
ENS EnerSys | $105.25
+1.9% | 5/24/2024 | Downgraded by | BTIG Research | Analyst G. Lewis | Buy -> Neutral | | Low | View details for BTIG Research rating of EnerSys (NYSE:ENS) on 5/24/2024 |
TYL Tyler Technologies | $472.90
+1.2% | 5/22/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $515.00 -> $550.00 | Low | View details for BTIG Research rating of Tyler Technologies (NYSE:TYL) on 5/22/2024 |
EXPE Expedia Group | $124.54
+0.4% | 5/21/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $175.00 -> $150.00 | Low | View details for BTIG Research rating of Expedia Group (NASDAQ:EXPE) on 5/21/2024 |
ABVX ABIVAX Société Anonyme | $13.55
| 5/20/2024 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $43.00 | Low | View details for BTIG Research rating of ABIVAX Société Anonyme (NASDAQ:ABVX) on 5/20/2024 |
DRI Darden Restaurants | $152.07
-1.0% | 5/17/2024 | Upgraded by | BTIG Research | Analyst P. Saleh | Neutral -> Buy | $175.00 | Low | View details for BTIG Research rating of Darden Restaurants (NYSE:DRI) on 5/17/2024 |
XTNT Xtant Medical | $0.72
-4.0% | 5/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $2.00 -> $3.00 | N/A | View details for BTIG Research rating of Xtant Medical (NYSEAMERICAN:XTNT) on 5/16/2024 |
BNGO Bionano Genomics | $0.78
-4.9% | 5/16/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $3.00 -> $2.00 | Low | View details for BTIG Research rating of Bionano Genomics (NASDAQ:BNGO) on 5/16/2024 |
TCRX TScan Therapeutics | $6.94
-6.7% | 5/16/2024 | Initiated by | BTIG Research | Analyst J. Zelin | Buy | $12.00 | Low | View details for BTIG Research rating of TScan Therapeutics (NASDAQ:TCRX) on 5/16/2024 |
FLUT Flutter Entertainment | $184.80
-2.1% | 5/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $242.00 -> $245.00 | Low | View details for BTIG Research rating of Flutter Entertainment (NYSE:FLUT) on 5/15/2024 |
BOOT Boot Barn | $133.81
+2.6% | 5/15/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $127.00 -> $125.00 | Low | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 5/15/2024 |
DNA Ginkgo Bioworks | $0.42
-2.3% | 5/15/2024 | Downgraded by | BTIG Research | Analyst M. Massaro | Neutral -> Sell | | Low | View details for BTIG Research rating of Ginkgo Bioworks (NYSE:DNA) on 5/15/2024 |
SFL SFL | $13.28
+0.9% | 5/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $15.00 -> $16.00 | Low | View details for BTIG Research rating of SFL (NYSE:SFL) on 5/14/2024 |
AKYA Akoya Biosciences | $2.14
+0.5% | 5/14/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $9.00 -> $6.00 | Low | View details for BTIG Research rating of Akoya Biosciences (NASDAQ:AKYA) on 5/14/2024 |
NTRA Natera | $107.99
-2.2% | 5/13/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $125.00 | Low | View details for BTIG Research rating of Natera (NASDAQ:NTRA) on 5/13/2024 |
RBLX Roblox | $35.90
| 5/10/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $54.00 -> $46.00 | Low | View details for BTIG Research rating of Roblox (NYSE:RBLX) on 5/10/2024 |
SYRE Spyre Therapeutics | $25.79
+1.4% | 5/10/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $32.00 -> $40.00 | Low | View details for BTIG Research rating of Spyre Therapeutics (NASDAQ:SYRE) on 5/10/2024 |
TDW Tidewater | $95.68
-0.7% | 5/10/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $110.00 -> $130.00 | Low | View details for BTIG Research rating of Tidewater (NYSE:TDW) on 5/10/2024 |
PGNY Progyny | $25.73
-3.7% | 5/10/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $50.00 -> $41.00 | Low | View details for BTIG Research rating of Progyny (NASDAQ:PGNY) on 5/10/2024 |
RANI Rani Therapeutics | $3.89
+2.1% | 5/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $7.00 -> $14.00 | Low | View details for BTIG Research rating of Rani Therapeutics (NASDAQ:RANI) on 5/9/2024 |
DCGO DocGo | $3.13
| 5/9/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $11.00 -> $7.00 | Low | View details for BTIG Research rating of DocGo (NASDAQ:DCGO) on 5/9/2024 |
EXAS Exact Sciences | $41.92
+1.4% | 5/9/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $85.00 -> $80.00 | Low | View details for BTIG Research rating of Exact Sciences (NASDAQ:EXAS) on 5/9/2024 |
APP AppLovin | $80.84
+3.0% | 5/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $87.00 -> $100.00 | Low | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 5/9/2024 |
INTA Intapp | $32.46
-3.7% | 5/8/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $55.00 -> $50.00 | Low | View details for BTIG Research rating of Intapp (NASDAQ:INTA) on 5/8/2024 |
FLYW Flywire | $15.39
-2.3% | 5/8/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $34.00 -> $27.00 | Low | View details for BTIG Research rating of Flywire (NASDAQ:FLYW) on 5/8/2024 |
GMED Globus Medical | $67.04
+0.5% | 5/8/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $60.00 -> $63.00 | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 5/8/2024 |
LULU Lululemon Athletica | $313.23
+0.1% | 5/8/2024 | Initiated by | BTIG Research | Analyst J. Stichter | Buy | $425.00 | Low | View details for BTIG Research rating of Lululemon Athletica (NASDAQ:LULU) on 5/8/2024 |
TMCI Treace Medical Concepts | $6.03
-0.8% | 5/8/2024 | Downgraded by | BTIG Research | Analyst R. Zimmerman | Buy -> Neutral | | Low | View details for BTIG Research rating of Treace Medical Concepts (NASDAQ:TMCI) on 5/8/2024 |
RXST RxSight | $57.07
+1.7% | 5/7/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $61.00 -> $72.00 | Low | View details for BTIG Research rating of RxSight (NASDAQ:RXST) on 5/7/2024 |
SHAK Shake Shack | $90.85
-2.9% | 5/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $120.00 -> $125.00 | Low | View details for BTIG Research rating of Shake Shack (NYSE:SHAK) on 5/6/2024 |
LYRA Lyra Therapeutics | $0.26
-3.7% | 5/6/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | N/A | View details for BTIG Research rating of Lyra Therapeutics (NASDAQ:LYRA) on 5/6/2024 |
DKNG DraftKings | $43.25
+3.1% | 5/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $53.00 -> $55.00 | Low | View details for BTIG Research rating of DraftKings (NASDAQ:DKNG) on 5/6/2024 |
TXRH Texas Roadhouse | $170.03
-0.9% | 5/3/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $155.00 -> $175.00 | Low | View details for BTIG Research rating of Texas Roadhouse (NASDAQ:TXRH) on 5/3/2024 |
SPT Sprout Social | $33.55
-0.2% | 5/3/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Sprout Social (NASDAQ:SPT) on 5/3/2024 |
GKOS Glaukos | $113.44
+1.3% | 5/2/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $107.00 -> $112.00 | Low | View details for BTIG Research rating of Glaukos (NYSE:GKOS) on 5/2/2024 |
NEO NeoGenomics | $13.01
-0.7% | 5/2/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $23.00 -> $21.00 | Low | View details for BTIG Research rating of NeoGenomics (NASDAQ:NEO) on 5/2/2024 |
QTWO Q2 | $57.86
-0.2% | 5/2/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $48.00 -> $60.00 | Low | View details for BTIG Research rating of Q2 (NYSE:QTWO) on 5/2/2024 |
ETSY Etsy | $57.67
-1.8% | 5/2/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $87.00 -> $78.00 | Low | View details for BTIG Research rating of Etsy (NASDAQ:ETSY) on 5/2/2024 |
UPWK Upwork | $10.20
-1.0% | 5/2/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $16.00 | Low | View details for BTIG Research rating of Upwork (NASDAQ:UPWK) on 5/2/2024 |
SBUX Starbucks | $80.20
-1.4% | 5/1/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $115.00 -> $100.00 | Low | View details for BTIG Research rating of Starbucks (NASDAQ:SBUX) on 5/1/2024 |
SYK Stryker | $348.67
+1.2% | 5/1/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $366.00 -> $369.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 5/1/2024 |
DPZ Domino's Pizza | $534.02
+0.3% | 4/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $515.00 -> $580.00 | Low | View details for BTIG Research rating of Domino’s Pizza (NYSE:DPZ) on 4/30/2024 |
WGS GeneDx | $27.60
-0.5% | 4/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $15.00 -> $19.00 | Low | View details for BTIG Research rating of GeneDx (NASDAQ:WGS) on 4/30/2024 |
STC Stewart Information Services | $62.21
+0.9% | 4/29/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $68.00 -> $70.00 | Low | View details for BTIG Research rating of Stewart Information Services (NYSE:STC) on 4/29/2024 |
BOOT Boot Barn | $133.81
+2.6% | 4/29/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $127.00 | Low | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 4/29/2024 |
CMG Chipotle Mexican Grill | $3,427.82
+1.9% | 4/25/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $3,250.00 -> $3,350.00 | Low | View details for BTIG Research rating of Chipotle Mexican Grill (NYSE:CMG) on 4/25/2024 |
HCP HashiCorp | $33.56
-0.1% | 4/24/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of HashiCorp (NASDAQ:HCP) on 4/24/2024 |
LFMD LifeMD | $7.87
-6.3% | 4/23/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $13.00 -> $14.00 | Low | View details for BTIG Research rating of LifeMD (NASDAQ:LFMD) on 4/23/2024 |
WGS GeneDx | $27.60
-0.5% | 4/22/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $11.00 -> $15.00 | Low | View details for BTIG Research rating of GeneDx (NASDAQ:WGS) on 4/22/2024 |
Must-See: Elon’s New Invention is Absolutely Insane (Ad) Could Elon's New Device be Bigger than the iPhone?
According to 30-year Silicon Valley and Wall Street veteran, Eric Fry…
This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… |
PINE Alpine Income Property Trust | $15.47
+0.6% | 4/22/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $23.00 -> $19.00 | Low | View details for BTIG Research rating of Alpine Income Property Trust (NYSE:PINE) on 4/22/2024 |
ISRG Intuitive Surgical | $435.00
+1.2% | 4/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $412.00 -> $421.00 | Low | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 4/19/2024 |
FVRR Fiverr International | $21.85
-2.3% | 4/18/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $30.00 -> $28.00 | Low | View details for BTIG Research rating of Fiverr International (NYSE:FVRR) on 4/18/2024 |
EFC Ellington Financial | $12.18
+0.1% | 4/18/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $15.50 -> $13.50 | Low | View details for BTIG Research rating of Ellington Financial (NYSE:EFC) on 4/18/2024 |
FIP FTAI Infrastructure | $8.37
+4.9% | 4/18/2024 | Initiated by | BTIG Research | - | Buy | $10.00 | Low | View details for BTIG Research rating of FTAI Infrastructure (NASDAQ:FIP) on 4/18/2024 |
CGEM Cullinan Therapeutics | $16.81
-11.6% | 4/17/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $20.00 -> $30.00 | N/A | View details for BTIG Research rating of Cullinan Therapeutics (NASDAQ:CGEM) on 4/17/2024 |
BXMT Blackstone Mortgage Trust | $17.93
| 4/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $24.00 -> $22.00 | N/A | View details for BTIG Research rating of Blackstone Mortgage Trust (NYSE:BXMT) on 4/17/2024 |
FBRT Franklin BSP Realty Trust | $12.96
-0.8% | 4/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $15.00 -> $14.00 | N/A | View details for BTIG Research rating of Franklin BSP Realty Trust (NYSE:FBRT) on 4/17/2024 |
RC Ready Capital | $8.40
-1.5% | 4/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $12.00 -> $10.00 | N/A | View details for BTIG Research rating of Ready Capital (NYSE:RC) on 4/17/2024 |
STWD Starwood Property Trust | $19.36
-0.3% | 4/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $24.00 -> $23.00 | N/A | View details for BTIG Research rating of Starwood Property Trust (NYSE:STWD) on 4/17/2024 |
XNCR Xencor | $19.44
-0.4% | 4/16/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $56.00 -> $38.00 | Low | View details for BTIG Research rating of Xencor (NASDAQ:XNCR) on 4/16/2024 |
DHI D.R. Horton | $139.41
-2.7% | 4/16/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $174.00 -> $169.00 | Low | View details for BTIG Research rating of D.R. Horton (NYSE:DHI) on 4/16/2024 |
HAFN Hafnia | $7.85
+2.9% | 4/12/2024 | Initiated by | BTIG Research | - | Buy | $10.00 | Low | View details for BTIG Research rating of Hafnia (NYSE:HAFN) on 4/12/2024 |
TBPH Theravance Biopharma | $8.48
+0.6% | 4/12/2024 | Initiated by | BTIG Research | - | Buy | $21.00 | Low | View details for BTIG Research rating of Theravance Biopharma (NASDAQ:TBPH) on 4/12/2024 |
CARM Carisma Therapeutics | $1.03
| 4/11/2024 | Initiated by | BTIG Research | - | Buy | $6.00 | Low | View details for BTIG Research rating of Carisma Therapeutics (NASDAQ:CARM) on 4/11/2024 |
RCEL AVITA Medical | $8.02
-1.4% | 4/11/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of AVITA Medical (NASDAQ:RCEL) on 4/11/2024 |
DCGO DocGo | $3.13
| 4/10/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $13.00 -> $11.00 | Low | View details for BTIG Research rating of DocGo (NASDAQ:DCGO) on 4/10/2024 |
APP AppLovin | $80.84
+3.0% | 4/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $65.00 -> $87.00 | Low | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 4/9/2024 |
OM Outset Medical | $3.64
-2.2% | 4/8/2024 | Initiated by | BTIG Research | - | Buy | $6.00 | Low | View details for BTIG Research rating of Outset Medical (NASDAQ:OM) on 4/8/2024 |
MSTR MicroStrategy | $1,469.43
-2.5% | 4/5/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $780.00 -> $1,800.00 | Low | View details for BTIG Research rating of MicroStrategy (NASDAQ:MSTR) on 4/5/2024 |
ADPT Adaptive Biotechnologies | $3.08
-1.9% | 4/4/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $6.00 -> $5.00 | Low | View details for BTIG Research rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 4/4/2024 |
RVLV Revolve Group | $15.87
-4.3% | 4/3/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $22.00 -> $24.00 | Low | View details for BTIG Research rating of Revolve Group (NYSE:RVLV) on 4/3/2024 |
KEX Kirby | $118.59
-0.1% | 4/3/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $115.00 | Low | View details for BTIG Research rating of Kirby (NYSE:KEX) on 4/3/2024 |
SHCR Sharecare | $0.80
| 4/1/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Sharecare (NASDAQ:SHCR) on 4/1/2024 |
PIII P3 Health Partners | $0.61
-4.7% | 4/1/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of P3 Health Partners (NASDAQ:PIII) on 4/1/2024 |
CMG Chipotle Mexican Grill | $3,427.82
+1.9% | 3/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $2,750.00 -> $3,250.00 | Low | View details for BTIG Research rating of Chipotle Mexican Grill (NYSE:CMG) on 3/28/2024 |
CYBR CyberArk Software | $255.05
+0.6% | 3/28/2024 | Initiated by | BTIG Research | - | Buy | $317.00 | Low | View details for BTIG Research rating of CyberArk Software (NASDAQ:CYBR) on 3/28/2024 |
OTLK Outlook Therapeutics | $7.07
-6.5% | 3/27/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $50.00 | Low | View details for BTIG Research rating of Outlook Therapeutics (NASDAQ:OTLK) on 3/27/2024 |
VKTX Viking Therapeutics | $50.64
-2.7% | 3/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $125.00 | Low | View details for BTIG Research rating of Viking Therapeutics (NASDAQ:VKTX) on 3/26/2024 |
NUVB Nuvation Bio | $2.90
-1.4% | 3/26/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $5.00 | Low | View details for BTIG Research rating of Nuvation Bio (NYSE:NUVB) on 3/26/2024 |
MASI Masimo | $135.80
+0.3% | 3/25/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $145.00 -> $166.00 | Low | View details for BTIG Research rating of Masimo (NASDAQ:MASI) on 3/25/2024 |
PZZA Papa John's International | $48.48
-0.6% | 3/22/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Papa John’s International (NASDAQ:PZZA) on 3/22/2024 |
SFL SFL | $13.28
+0.9% | 3/20/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $13.00 -> $15.00 | Low | View details for BTIG Research rating of SFL (NYSE:SFL) on 3/20/2024 |
HQY HealthEquity | $84.74
+0.4% | 3/20/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $110.00 | Low | View details for BTIG Research rating of HealthEquity (NASDAQ:HQY) on 3/20/2024 |
JANX Janux Therapeutics | $40.40
+0.8% | 3/21/2024 | Initiated by | BTIG Research | - | Buy | $62.00 | Low | View details for BTIG Research rating of Janux Therapeutics (NASDAQ:JANX) on 3/21/2024 |
USFD US Foods | $53.15
-0.4% | 3/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $52.00 -> $62.00 | Low | View details for BTIG Research rating of US Foods (NYSE:USFD) on 3/19/2024 |
CLSK CleanSpark | $19.48
+1.2% | 3/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $12.00 -> $22.00 | Low | View details for BTIG Research rating of CleanSpark (NASDAQ:CLSK) on 3/19/2024 |
TDW Tidewater | $95.68
-0.7% | 3/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $90.00 -> $110.00 | Low | View details for BTIG Research rating of Tidewater (NYSE:TDW) on 3/19/2024 |
MXCT MaxCyte | $4.41
-6.0% | 3/13/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $10.00 -> $8.00 | Low | View details for BTIG Research rating of MaxCyte (NASDAQ:MXCT) on 3/13/2024 |
SHAK Shake Shack | $90.85
-2.9% | 3/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $110.00 -> $120.00 | Low | View details for BTIG Research rating of Shake Shack (NYSE:SHAK) on 3/14/2024 |
LFMD LifeMD | $7.87
-6.3% | 3/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $11.00 -> $13.00 | N/A | View details for BTIG Research rating of LifeMD (NASDAQ:LFMD) on 3/15/2024 |
VKTX Viking Therapeutics | $50.64
-2.7% | 3/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $86.00 -> $100.00 | Low | View details for BTIG Research rating of Viking Therapeutics (NASDAQ:VKTX) on 3/15/2024 |
GMED Globus Medical | $67.04
+0.5% | 3/18/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $60.00 | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 3/18/2024 |
BTDR Bitdeer Technologies Group | $9.08
-3.2% | 3/13/2024 | Initiated by | BTIG Research | - | Buy | $15.00 | Low | View details for BTIG Research rating of Bitdeer Technologies Group (NASDAQ:BTDR) on 3/13/2024 |
TKNO Alpha Teknova | $1.60
-7.0% | 3/12/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Alpha Teknova (NASDAQ:TKNO) on 3/12/2024 |
IDYA IDEAYA Biosciences | $37.27
-0.8% | 3/8/2024 | Initiated by | BTIG Research | - | Buy | $55.00 | Low | View details for BTIG Research rating of IDEAYA Biosciences (NASDAQ:IDYA) on 3/8/2024 |
GNL Global Net Lease | $7.13
-1.0% | 3/8/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Global Net Lease (NYSE:GNL) on 3/8/2024 |
ZLDPF Zealand Pharma A/S | $90.80
-3.0% | 3/7/2024 | Initiated by | BTIG Research | - | Buy | | Low | View details for BTIG Research rating of Zealand Pharma A/S (OTCMKTS:ZLDPF) on 3/7/2024 |
SOPH SOPHiA GENETICS | $4.99
+0.8% | 3/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $7.00 -> $8.00 | Low | View details for BTIG Research rating of SOPHiA GENETICS (NASDAQ:SOPH) on 3/6/2024 |
CRWD CrowdStrike | $389.51
-0.2% | 3/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $322.00 -> $432.00 | N/A | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
Must-See: Elon’s New Invention is Absolutely Insane (Ad) Could Elon's New Device be Bigger than the iPhone?
According to 30-year Silicon Valley and Wall Street veteran, Eric Fry…
This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… |
HCP HashiCorp | $33.56
-0.1% | 3/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $25.00 -> $27.00 | Low | View details for BTIG Research rating of HashiCorp (NASDAQ:HCP) on 3/6/2024 |
MGNX MacroGenics | $4.12
-4.0% | 3/4/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $12.00 -> $24.00 | Low | View details for BTIG Research rating of MacroGenics (NASDAQ:MGNX) on 3/4/2024 |
MRSN Mersana Therapeutics | $2.04
| 2/29/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $6.00 | Low | View details for BTIG Research rating of Mersana Therapeutics (NASDAQ:MRSN) on 2/29/2024 |
BMBL Bumble | $10.08
-5.1% | 2/28/2024 | Target Lowered by | BTIG Research | - | Buy | $20.00 -> $15.00 | Low | View details for BTIG Research rating of Bumble (NASDAQ:BMBL) on 2/28/2024 |
ANAB AnaptysBio | $22.89
-2.1% | 2/26/2024 | Initiated by | BTIG Research | - | Buy | $55.00 | Low | View details for BTIG Research rating of AnaptysBio (NASDAQ:ANAB) on 2/26/2024 |
TTD Trade Desk | $99.25
+1.6% | 2/23/2024 | Target Raised by | BTIG Research | - | Buy | $91.00 -> $98.00 | Low | View details for BTIG Research rating of Trade Desk (NASDAQ:TTD) on 2/23/2024 |
PLL Piedmont Lithium | $10.14
-5.0% | 2/23/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Piedmont Lithium (NASDAQ:PLL) on 2/23/2024 |
ETSY Etsy | $57.67
-1.8% | 2/22/2024 | Target Lowered by | BTIG Research | - | Buy | $90.00 -> $87.00 | Low | View details for BTIG Research rating of Etsy (NASDAQ:ETSY) on 2/22/2024 |
UBER Uber Technologies | $70.33
-0.2% | 2/22/2024 | Target Raised by | BTIG Research | - | Buy | $80.00 -> $90.00 | Low | View details for BTIG Research rating of Uber Technologies (NYSE:UBER) on 2/22/2024 |
FLYX flyExclusive | $4.41
+3.8% | 2/22/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of flyExclusive (NYSE:FLYX) on 2/22/2024 |
GHLD Guild | $14.61
-2.1% | 2/21/2024 | Initiated by | BTIG Research | - | Buy | $18.00 | Low | View details for BTIG Research rating of Guild (NYSE:GHLD) on 2/21/2024 |
IQV IQVIA | $212.93
-0.2% | 2/13/2024 | Initiated by | BTIG Research | - | Buy | $285.00 | Low | View details for BTIG Research rating of IQVIA (NYSE:IQV) on 2/13/2024 |
PYXS Pyxis Oncology | $3.42
-6.6% | 2/9/2024 | Initiated by | BTIG Research | - | Buy | $8.00 | Low | View details for BTIG Research rating of Pyxis Oncology (NASDAQ:PYXS) on 2/9/2024 |
CMG Chipotle Mexican Grill | $3,427.82
+1.9% | 2/7/2024 | Target Raised by | BTIG Research | - | Buy | $2,650.00 -> $2,750.00 | Low | View details for BTIG Research rating of Chipotle Mexican Grill (NYSE:CMG) on 2/7/2024 |
PCTY Paylocity | $133.87
-3.0% | 2/6/2024 | Initiated by | BTIG Research | - | Buy | $200.00 | Low | View details for BTIG Research rating of Paylocity (NASDAQ:PCTY) on 2/6/2024 |
PYCR Paycor HCM | $11.15
-3.0% | 2/6/2024 | Initiated by | BTIG Research | - | Buy | $26.00 | Low | View details for BTIG Research rating of Paycor HCM (NASDAQ:PYCR) on 2/6/2024 |
PAYC Paycom Software | $141.46
-1.0% | 2/6/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Paycom Software (NYSE:PAYC) on 2/6/2024 |
MCD McDonald's | $250.79
-1.1% | 2/6/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of McDonald’s (NYSE:MCD) on 2/6/2024 |
BOOT Boot Barn | $133.81
+2.6% | 2/1/2024 | Target Lowered by | BTIG Research | - | Buy | $102.00 -> $100.00 | Low | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 2/1/2024 |
SBUX Starbucks | $80.20
-1.4% | 1/31/2024 | Target Lowered by | BTIG Research | - | Buy | $125.00 -> $115.00 | Low | View details for BTIG Research rating of Starbucks (NASDAQ:SBUX) on 1/31/2024 |
SQ Block | $61.89
-1.0% | 1/30/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $85.00 | Low | View details for BTIG Research rating of Block (NYSE:SQ) on 1/30/2024 |
PNST Pinstripes | $2.75
-0.4% | 1/29/2024 | Initiated by | BTIG Research | - | Buy | $6.00 | Low | View details for BTIG Research rating of Pinstripes (NYSE:PNST) on 1/29/2024 |
CCSI Consensus Cloud Solutions | $16.29
-6.2% | 1/26/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 1/26/2024 |
BE Bloom Energy | $13.64
-2.2% | 1/25/2024 | Initiated by | BTIG Research | - | Buy | $21.00 | Low | View details for BTIG Research rating of Bloom Energy (NYSE:BE) on 1/25/2024 |
MDAI Spectral AI | $1.59
-6.5% | 1/23/2024 | Initiated by | BTIG Research | - | Buy | $4.00 | Low | View details for BTIG Research rating of Spectral AI (NASDAQ:MDAI) on 1/23/2024 |
FLYX flyExclusive | $4.41
+3.8% | 1/23/2024 | Initiated by | BTIG Research | - | Buy | $9.00 | Low | View details for BTIG Research rating of flyExclusive (NYSE:FLYX) on 1/23/2024 |
S SentinelOne | $18.17
-1.4% | 1/22/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $30.00 | Low | View details for BTIG Research rating of SentinelOne (NYSE:S) on 1/22/2024 |
MTTR Matterport | $4.11
-0.2% | 1/19/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Matterport (NASDAQ:MTTR) on 1/19/2024 |
SMRT SmartRent | $2.40
-0.4% | 1/19/2024 | Initiated by | BTIG Research | - | Buy | $4.50 | Low | View details for BTIG Research rating of SmartRent (NYSE:SMRT) on 1/19/2024 |
CSGP CoStar Group | $72.73
-0.6% | 1/19/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of CoStar Group (NASDAQ:CSGP) on 1/19/2024 |
APPF AppFolio | $231.76
+0.7% | 1/19/2024 | Initiated by | BTIG Research | - | Buy | $215.00 | Low | View details for BTIG Research rating of AppFolio (NASDAQ:APPF) on 1/19/2024 |
PSFE Paysafe | $17.66
+0.7% | 1/17/2024 | Initiated by | BTIG Research | - | Buy | $19.00 | Low | View details for BTIG Research rating of Paysafe (NYSE:PSFE) on 1/17/2024 |
MARA Marathon Digital | $20.28
+1.3% | 1/17/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $27.00 | Low | View details for BTIG Research rating of Marathon Digital (NASDAQ:MARA) on 1/17/2024 |
ACRS Aclaris Therapeutics | $1.13
| 1/11/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Aclaris Therapeutics (NASDAQ:ACRS) on 1/11/2024 |
BIIB Biogen | $223.65
-1.2% | 1/7/2024 | Reiterated by | BTIG Research | Analyst T. Shrader | Neutral | | Low | View details for BTIG Research rating of Biogen (NASDAQ:BIIB) on 1/7/2024 |
PYPL PayPal | $59.12
-1.7% | 1/5/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of PayPal (NASDAQ:PYPL) on 1/5/2024 |
GOGL Golden Ocean Group | $13.02
+0.9% | 1/5/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Golden Ocean Group (NASDAQ:GOGL) on 1/5/2024 |
GNK Genco Shipping & Trading | $20.41
+0.6% | 1/5/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Genco Shipping & Trading (NYSE:GNK) on 1/5/2024 |
CMG Chipotle Mexican Grill | $3,427.82
+1.9% | 1/4/2024 | Target Raised by | BTIG Research | - | Buy | $2,175.00 -> $2,650.00 | Low | View details for BTIG Research rating of Chipotle Mexican Grill (NYSE:CMG) on 1/4/2024 |
NTRA Natera | $107.99
-2.2% | 12/29/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $75.00 -> $85.00 | Low | View details for BTIG Research rating of Natera (NASDAQ:NTRA) on 12/29/2023 |
NEO NeoGenomics | $13.01
-0.7% | 12/29/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $25.00 -> $21.00 | Low | View details for BTIG Research rating of NeoGenomics (NASDAQ:NEO) on 12/29/2023 |
HPP Hudson Pacific Properties | $4.85
-0.4% | 12/29/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $11.00 -> $13.00 | Low | View details for BTIG Research rating of Hudson Pacific Properties (NYSE:HPP) on 12/29/2023 |
BSX Boston Scientific | $76.34
+0.2% | 12/29/2023 | Reiterated by | BTIG Research | - | Buy -> Buy | $64.00 | Low | View details for BTIG Research rating of Boston Scientific (NYSE:BSX) on 12/29/2023 |
LSPD Lightspeed Commerce | $13.60
-5.5% | 12/28/2023 | Target Raised by | BTIG Research | - | Buy | $20.00 -> $24.00 | Low | View details for BTIG Research rating of Lightspeed Commerce (NYSE:LSPD) on 12/28/2023 |
ORGO Organogenesis | $2.47
-3.9% | 12/27/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $4.00 -> $6.00 | Low | View details for BTIG Research rating of Organogenesis (NASDAQ:ORGO) on 12/27/2023 |
EXPE Expedia Group | $124.54
+0.4% | 12/27/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $150.00 -> $175.00 | Low | View details for BTIG Research rating of Expedia Group (NASDAQ:EXPE) on 12/27/2023 |
OVID Ovid Therapeutics | $0.79
| 12/21/2023 | Initiated by | BTIG Research | - | Buy | $11.00 | Low | View details for BTIG Research rating of Ovid Therapeutics (NASDAQ:OVID) on 12/21/2023 |
SYRE Spyre Therapeutics | $25.79
+1.4% | 12/20/2023 | Initiated by | BTIG Research | - | Buy | $32.00 | Low | View details for BTIG Research rating of Spyre Therapeutics (NASDAQ:SYRE) on 12/20/2023 |
APGE Apogee Therapeutics | $36.37
-6.7% | 12/20/2023 | Initiated by | BTIG Research | - | Buy | $43.00 | Low | View details for BTIG Research rating of Apogee Therapeutics (NASDAQ:APGE) on 12/20/2023 |
OPEN Opendoor Technologies | $1.97
-1.0% | 12/20/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | N/A | View details for BTIG Research rating of Opendoor Technologies (NASDAQ:OPEN) on 12/20/2023 |
Must-See: Elon’s New Invention is Absolutely Insane (Ad) Could Elon's New Device be Bigger than the iPhone?
According to 30-year Silicon Valley and Wall Street veteran, Eric Fry…
This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… |
EXEL Exelixis | $21.56
-1.0% | 12/19/2023 | Initiated by | BTIG Research | - | Buy | $27.00 | Low | View details for BTIG Research rating of Exelixis (NASDAQ:EXEL) on 12/19/2023 |
TRIP Tripadvisor | $18.00
-0.5% | 12/14/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $25.00 | Low | View details for BTIG Research rating of Tripadvisor (NASDAQ:TRIP) on 12/14/2023 |
VEL Velocity Financial | $18.37
-1.4% | 12/12/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $14.00 -> $17.00 | N/A | View details for BTIG Research rating of Velocity Financial (NYSE:VEL) on 12/12/2023 |
CLSK CleanSpark | $19.48
+1.2% | 12/11/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $10.00 -> $12.00 | Low | View details for BTIG Research rating of CleanSpark (NASDAQ:CLSK) on 12/11/2023 |
MSTR MicroStrategy | $1,469.43
-2.5% | 12/11/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $560.00 -> $690.00 | Low | View details for BTIG Research rating of MicroStrategy (NASDAQ:MSTR) on 12/11/2023 |
HCP HashiCorp | $33.56
-0.1% | 12/8/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $33.00 -> $25.00 | Low | View details for BTIG Research rating of HashiCorp (NASDAQ:HCP) on 12/8/2023 |
AURA Aura Biosciences | $7.05
-4.7% | 12/8/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $38.00 -> $21.00 | Low | View details for BTIG Research rating of Aura Biosciences (NASDAQ:AURA) on 12/8/2023 |
DECK Deckers Outdoor | $1,008.46
-0.9% | 12/7/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $650.00 -> $800.00 | Low | View details for BTIG Research rating of Deckers Outdoor (NYSE:DECK) on 12/7/2023 |
BRZE Braze | $35.13
-0.8% | 12/7/2023 | Target Raised by | BTIG Research | - | Buy | $60.00 -> $75.00 | Low | View details for BTIG Research rating of Braze (NASDAQ:BRZE) on 12/7/2023 |
CXM Sprinklr | $8.56
-2.9% | 12/7/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Sprinklr (NYSE:CXM) on 12/7/2023 |
AVDX AvidXchange | $10.98
+0.6% | 12/6/2023 | Initiated by | BTIG Research | - | Buy | $14.00 | Low | View details for BTIG Research rating of AvidXchange (NASDAQ:AVDX) on 12/6/2023 |
XTNT Xtant Medical | $0.72
-4.0% | 12/5/2023 | Initiated by | BTIG Research | - | Buy | $2.00 | N/A | View details for BTIG Research rating of Xtant Medical (NYSEAMERICAN:XTNT) on 12/5/2023 |
RWT Redwood Trust | $6.55
-1.8% | 12/5/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $8.50 | Low | View details for BTIG Research rating of Redwood Trust (NYSE:RWT) on 12/5/2023 |
STC Stewart Information Services | $62.21
+0.9% | 12/4/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $70.00 | Low | View details for BTIG Research rating of Stewart Information Services (NYSE:STC) on 12/4/2023 |
AKBA Akebia Therapeutics | $1.01
-3.8% | 11/29/2023 | Reiterated by | BTIG Research | - | Buy | $4.00 | Low | View details for BTIG Research rating of Akebia Therapeutics (NASDAQ:AKBA) on 11/29/2023 |
CRWD CrowdStrike | $389.51
-0.2% | 11/27/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $192.00 -> $239.00 | Low | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 11/27/2023 |
ZS Zscaler | $179.41
-2.7% | 11/22/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $191.00 -> $229.00 | Low | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 11/22/2023 |
NTST NETSTREIT | $17.09
+0.6% | 11/22/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $23.00 -> $19.00 | Low | View details for BTIG Research rating of NETSTREIT (NYSE:NTST) on 11/22/2023 |
VSTM Verastem | $3.27
-5.8% | 11/21/2023 | Reiterated by | BTIG Research | - | Buy | $27.00 | Low | View details for BTIG Research rating of Verastem (NASDAQ:VSTM) on 11/21/2023 |
OXM Oxford Industries | $100.70
-1.1% | 11/21/2023 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Oxford Industries (NYSE:OXM) on 11/21/2023 |
FL Foot Locker | $25.11
+3.2% | 11/21/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Foot Locker (NYSE:FL) on 11/21/2023 |
GPN Global Payments | $92.19
-1.8% | 11/20/2023 | Initiated by | BTIG Research | - | Buy | $135.00 | Low | View details for BTIG Research rating of Global Payments (NYSE:GPN) on 11/20/2023 |
WKHS Workhorse Group | $1.88
-14.9% | 11/15/2023 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Workhorse Group (NASDAQ:WKHS) on 11/15/2023 |
GP GreenPower Motor | $1.10
| 11/15/2023 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of GreenPower Motor (NASDAQ:GP) on 11/15/2023 |
NOTE FiscalNote | $1.36
-2.9% | 11/15/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of FiscalNote (NYSE:NOTE) on 11/15/2023 |
RBOT Vicarious Surgical | $6.72
-2.0% | 11/14/2023 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Vicarious Surgical (NYSE:RBOT) on 11/14/2023 |
GTLB GitLab | $43.01
-1.0% | 11/13/2023 | Initiated by | BTIG Research | - | Buy | $56.00 | Low | View details for BTIG Research rating of GitLab (NASDAQ:GTLB) on 11/13/2023 |
VUZI Vuzix | $1.33
-2.9% | 11/10/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Vuzix (NASDAQ:VUZI) on 11/10/2023 |
MODN Model N | $29.93
| 11/10/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Model N (NYSE:MODN) on 11/10/2023 |
FREY FREYR Battery | $1.71
-1.2% | 11/10/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of FREYR Battery (NYSE:FREY) on 11/10/2023 |
LVLU Lulu's Fashion Lounge | $1.77
-1.7% | 11/9/2023 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Lulu’s Fashion Lounge (NASDAQ:LVLU) on 11/9/2023 |
DNA Ginkgo Bioworks | $0.42
-2.3% | 11/9/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Ginkgo Bioworks (NYSE:DNA) on 11/9/2023 |
OMCL Omnicell | $27.46
-1.6% | 11/3/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Omnicell (NASDAQ:OMCL) on 11/3/2023 |
DECK Deckers Outdoor | $1,008.46
-0.9% | 10/27/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $640.00 -> $650.00 | Low | View details for BTIG Research rating of Deckers Outdoor (NYSE:DECK) on 10/27/2023 |
SHYF The Shyft Group | $12.27
+0.9% | 10/27/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of The Shyft Group (NASDAQ:SHYF) on 10/27/2023 |
HR Healthcare Realty Trust | $16.22
+0.4% | 10/24/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $17.00 | Low | View details for BTIG Research rating of Healthcare Realty Trust (NYSE:HR) on 10/24/2023 |
SKLZ Skillz | $6.78
-1.2% | 10/23/2023 | Upgraded by | BTIG Research | - | Sell -> Neutral | | Low | View details for BTIG Research rating of Skillz (NYSE:SKLZ) on 10/23/2023 |
VEL Velocity Financial | $18.37
-1.4% | 10/23/2023 | Initiated by | BTIG Research | - | Buy | $14.00 | N/A | View details for BTIG Research rating of Velocity Financial (NYSE:VEL) on 10/23/2023 |
IVR Invesco Mortgage Capital | $9.25
-1.3% | 10/20/2023 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Invesco Mortgage Capital (NYSE:IVR) on 10/20/2023 |
GMAB Genmab A/S | $25.80
+0.1% | 10/13/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $44.00 -> $46.00 | Low | View details for BTIG Research rating of Genmab A/S (NASDAQ:GMAB) on 10/13/2023 |
MTNB Matinas BioPharma | $0.15
-6.3% | 10/11/2023 | Reiterated by | BTIG Research | - | Buy -> Buy | $3.00 | N/A | View details for BTIG Research rating of Matinas BioPharma (NYSEAMERICAN:MTNB) on 10/11/2023 |
WRBY Warby Parker | $15.36
-0.8% | 10/12/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $17.00 | Low | View details for BTIG Research rating of Warby Parker (NYSE:WRBY) on 10/12/2023 |
LYRA Lyra Therapeutics | $0.26
-3.7% | 10/6/2023 | Reiterated by | BTIG Research | - | Buy | $15.00 | Low | View details for BTIG Research rating of Lyra Therapeutics (NASDAQ:LYRA) on 10/6/2023 |
ETSY Etsy | $57.67
-1.8% | 10/6/2023 | Target Lowered by | BTIG Research | - | | $108.00 -> $90.00 | Low | View details for BTIG Research rating of Etsy (NASDAQ:ETSY) on 10/6/2023 |
UWMC UWM | $7.26
-1.6% | 10/5/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $6.00 | Low | View details for BTIG Research rating of UWM (NYSE:UWMC) on 10/5/2023 |
KIDS OrthoPediatrics | $29.94
+1.8% | 10/3/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $59.00 -> $52.00 | Low | View details for BTIG Research rating of OrthoPediatrics (NASDAQ:KIDS) on 10/3/2023 |
PMN ProMIS Neurosciences | $1.56
+2.6% | 10/2/2023 | Initiated by | BTIG Research | - | Buy | $8.00 | Low | View details for BTIG Research rating of ProMIS Neurosciences (NASDAQ:PMN) on 10/2/2023 |
MCD McDonald's | $250.79
-1.1% | 10/2/2023 | Target Lowered by | BTIG Research | - | | $315.00 -> $300.00 | Low | View details for BTIG Research rating of McDonald’s (NYSE:MCD) on 10/2/2023 |
RBLX Roblox | $35.90
| 10/2/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $54.00 -> $52.00 | Low | View details for BTIG Research rating of Roblox (NYSE:RBLX) on 10/2/2023 |
LGIH LGI Homes | $91.93
-3.1% | 10/2/2023 | Upgraded by | BTIG Research | - | Sell -> Neutral | | Low | View details for BTIG Research rating of LGI Homes (NASDAQ:LGIH) on 10/2/2023 |
INSW International Seaways | $56.46
+2.6% | 9/28/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $45.00 -> $55.00 | Low | View details for BTIG Research rating of International Seaways (NYSE:INSW) on 9/28/2023 |
FLYW Flywire | $15.39
-2.3% | 9/28/2023 | Initiated by | BTIG Research | - | Buy | $37.00 | Low | View details for BTIG Research rating of Flywire (NASDAQ:FLYW) on 9/28/2023 |
TRUE TrueCar | $2.77
-1.1% | 9/27/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of TrueCar (NASDAQ:TRUE) on 9/27/2023 |
LYFT Lyft | $13.78
-2.1% | 9/26/2023 | Reiterated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Lyft (NASDAQ:LYFT) on 9/26/2023 |
APP AppLovin | $80.84
+3.0% | 9/26/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $40.00 -> $46.00 | Low | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 9/26/2023 |
HPP Hudson Pacific Properties | $4.85
-0.4% | 9/26/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $11.00 | Low | View details for BTIG Research rating of Hudson Pacific Properties (NYSE:HPP) on 9/26/2023 |
CSR Centerspace | $68.10
+1.1% | 9/25/2023 | Reiterated by | BTIG Research | - | Buy | $69.00 | Low | View details for BTIG Research rating of Centerspace (NYSE:CSR) on 9/25/2023 |
MORF Morphic | $26.16
+0.2% | 9/25/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Morphic (NASDAQ:MORF) on 9/25/2023 |
CART Maplebear | $33.84
+1.8% | 9/22/2023 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Maplebear (NASDAQ:CART) on 9/22/2023 |
BSX Boston Scientific | $76.34
+0.2% | 9/21/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $62.00 -> $64.00 | Low | View details for BTIG Research rating of Boston Scientific (NYSE:BSX) on 9/21/2023 |
